29 July 2025

A sea of struggle: Jorge Ibáñez swims across the Strait of Gibraltar for his friend with ALS

The swimmer completed the 15,1 kilometers between Tarifa and Punta Cires in 3 hours and 12 minutes to highlight the struggles of those affected by this neurodegenerative disease.
6 May 2025

A new experimental drug improves motor function and prolongs life in an ALS model.

The MP-010 molecule, developed by Miramoon Pharma, acts on ryanodine receptors, opening a new therapeutic avenue for treating ALS, according to a study led by researchers from CIBERNED and several research institutes, including the IIS Aragón.
21 February, 2025

Neurodegenerative diseases: the virus-brain connection

Researchers Isidoro Martínez González and Salvador Resino García, both from the Carlos III Health Institute (ISCIII), have published an article where scientific evidence links the presence of certain viruses with diseases such as Alzheimer's, Parkinson's and ALS.
September 20, 2024

A new blood test for rapid diagnosis of ALS

A blood test can detect this neurodegenerative disease with 98% accuracy and within 24 hours. The speed of this process will allow treatment to be started earlier, which will translate into better results for patients, say the researchers. It is expected to be available to neurologists within 18 to 24 months.